Drug Discovery

We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

This is the story of how DNDi put forward a new model for collaborative, open science.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

What will drug development look like aboard a new commercial space station?